Impact of β-blockers on survival outcomes in patients with unresectable hepatocellular carcinoma

BACKGROUND: β-blockers (BBs) have shown promise in improving overall survival (OS) in patients with breast, ovarian, pancreatic and lung cancer. However, few studies have evaluated the impact of BBs on unresectable hepatocellular carcinoma (HCC). METHODS: The authors compared clinical data and outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Altshuler, Ellery, Aryan, Mahmoud, Kallumkal, Govind, Gao, Hanzhi, Wilson, Jake, Ouni, Ahmed, De Leo, Edward, Hanayneh, Wissam, Pan, Kelsey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136628/
https://www.ncbi.nlm.nih.gov/pubmed/35665305
http://dx.doi.org/10.2217/hep-2021-0010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136628/
https://www.ncbi.nlm.nih.gov/pubmed/35665305
http://dx.doi.org/10.2217/hep-2021-0010

Ejemplares similares